CHEMICAL/BIOLOGICAL DEFENSE (ATD)
Abstract
The projects in this program element (PE) demonstrate technologies supporting transition to advanced component development for physical capabilities which cover biological and chemical detection, situational awareness and effects modeling, and protection and hazard mitigation. Other major efforts support enhanced chemical detection capabilities for aerosols and non-traditional agents, expanded capabilities for early warning in pathogen detection and diagnosis, and pretreatments and therapeutics against a broader set of chemical and biological agents. Medical capabilities (pretreatments, therapeutics, diagnostics capabilities, and drug manufacturing and regulatory science technologies), include capabilities against non-traditional agents. Individual projects include: - Chemical Biological Defense (CB3): demonstrations of CB physical science defense technologies, including biological detection, chemical detection, digital battlespace management, and protection, and decontamination. This project continues to pursue solutions against traditional agents. - Non-Traditional Agents (NTA) Defense (NT3): supports all efforts (both medical and non-medical) including chemical diagnostics, medical pretreatments, therapeutics, detection, and protection and hazard mitigation. Starting in FY21, an administrative change pertaining to efforts of improving S&T budget agility and transition efficiency was applied by merging a portion of the NTA lines to RDT&E Projects CB3, Chemical Biological Defense and TM3, Techbase Medical Defense. - Techbase Medical Defense (TM3): aims to produce biological diagnostic assays and reagents, diagnostic device platforms, pretreatments and therapeutics for bacterial, viral, and toxin threats as well as for chemical threats, and medical devices, as countermeasures for CBR threat agents. Specific areas of medical investigation include: prophylaxis, pretreatment, antidotes and therapeutics, personnel and patient decontamination, and medical management of casualties. - Technology Transition (TT3): pursues federal R&D or commercially available products to enhance military operational capability, concepts of operation, WMD elimination, and hazard mitigation following a biological warfare or chemical warfare attack. The CBDP S&T Advanced Technology Development stakeholders: The U.S. Army Combat Capabilities Development Command Chemical Biological Center (CCDC CBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. Work conducted under this PE will transition to and will provide risk reduction for Advanced Component Development and Prototypes (PE 0603884BP) and System Development and Demonstration (PE 0604384BP) activities.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2021
- Source ID
- 0603384BP_3_0400_PB_2021
- Change Summary Explanation
- Funding: FY19 (-$0.183 Million): Reprogramming adjustments to balance overall portfolio efforts. FY19 (-$1.902 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY20 (+3.000 Million): Congressional Add for Improved Gas Particulate Filter Unit. FY21 (-$3.379 Million): Program adjustments to align chem bio incident preparedness and response efforts and techbase technology transition efforts to advanced development (-$3.078 Million), as well as Departmental economic adjustments (-$0.301 Million). Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: Chemical Biological Defense (ATD)
- Child Accomplishment: 1) Expeditionary Collective Protection
- Child Accomplishment: 2) Material Contamination Mitigation
- Child Accomplishment: 3) Percutaneous Protection
- Child Accomplishment: 4) Respiratory and Ocular Protection
- Child Accomplishment: 5) Detection
- Child Accomplishment: 6) Hazard Prediction
- Child Accomplishment: 7) Data Analysis
- Child Accomplishment: 8) Operational Effects
- Child Accomplishment: 9) Decision Analysis and Management
- Child Accomplishment: 10) Threat Surveillance
- Child Accomplishment: 11) Warning and Reporting
- Child Project: Non-Traditional Agents Defense (ATD)
- Child Accomplishment: 1) Material Contamination Mitigation
- Child Accomplishment: 2) Personnel Contamination Mitigation
- Child Accomplishment: 3) Respiratory and Ocular Protection
- Child Accomplishment: 4) Therapeutics - Medical
- Child Accomplishment: 5) Detection
- Child Accomplishment: 6) Modeling & Simulation
- Child Accomplishment: 7) Percutaneous Protection
- Child Accomplishment: 8) Test & Evaluation
- Child Accomplishment: 9) Pretreatments and Prophylactics - Medical
- Child Project: Techbase Medical Defense (ATD)
- Child Accomplishment: 1) Bacterial Therapeutics
- Child Accomplishment: 2) Bacterial/Toxin Vaccines
- Child Accomplishment: 3) Medical Countermeasures Initiative
- Child Accomplishment: 4) Vaccine Platforms and Research Tools
- Child Accomplishment: 5) Viral Therapeutics
- Child Accomplishment: 6) Viral Vaccines
- Child Accomplishment: 7) Medical Diagnostics
- Child Accomplishment: 8) Chemical Therapeutics
- Child Accomplishment: 9) Medical Diagnostics Response Capability Development
- Child Project: Technology Transition (ATD)
- Child Accomplishment: 1) Experiment & Technology Demonstrations